POMDOCTOR receives Nasdaq delisting determination over minimum bid price; intends to appeal

POMDOCTOR says it received a Nasdaq delisting determination and intends to timely request a hearing before the panel to appeal the staff's determination and present a plan to regain compliance with the minimum bid price requirement. The deadline to request a hearing is October 13, 2026.

Detected & updated continuously · Source: Nebula